A 3-way, double-blind, randomized, crossover trial to evaluate effects of nebivolol and valsartan alone and in combination on 24-hour ambulatory rate-pressure product, stroke load, and blood pressure-heart rate variability in patients with hypertension.
Phase of Trial: Phase II
Latest Information Update: 15 Jun 2015
At a glance
- Drugs Nebivolol (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.